Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1966 2
1989 1
1992 2
1993 1
1996 1
1997 4
1998 6
1999 2
2000 2
2001 7
2002 3
2003 1
2004 5
2005 3
2006 6
2007 3
2008 3
2009 7
2010 8
2011 12
2012 8
2013 16
2014 23
2015 26
2016 22
2017 30
2018 24
2019 20
2020 49
2021 39
2022 36
2023 28
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

364 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Luke JJ, Rutkowski P, Queirolo P, Del Vecchio M, Mackiewicz J, Chiarion-Sileni V, de la Cruz Merino L, Khattak MA, Schadendorf D, Long GV, Ascierto PA, Mandala M, De Galitiis F, Haydon A, Dummer R, Grob JJ, Robert C, Carlino MS, Mohr P, Poklepovic A, Sondak VK, Scolyer RA, Kirkwood JM, Chen K, Diede SJ, Ahsan S, Ibrahim N, Eggermont AMM; KEYNOTE-716 Investigators. Luke JJ, et al. Among authors: ahsan s. Lancet. 2022 Apr 30;399(10336):1718-1729. doi: 10.1016/S0140-6736(22)00562-1. Epub 2022 Apr 1. Lancet. 2022. PMID: 35367007 Clinical Trial.
Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma.
Grossmann KF, Othus M, Patel SP, Tarhini AA, Sondak VK, Knopp MV, Petrella TM, Truong TG, Khushalani NI, Cohen JV, Buchbinder EI, Kendra K, Funchain P, Lewis KD, Conry RM, Chmielowski B, Kudchadkar RR, Johnson DB, Li H, Moon J, Eroglu Z, Gastman B, Kovacsovics-Bankowski M, Gunturu KS, Ebbinghaus SW, Ahsan S, Ibrahim N, Sharon E, Korde LA, Kirkwood JM, Ribas A. Grossmann KF, et al. Among authors: ahsan s. Cancer Discov. 2022 Mar 1;12(3):644-653. doi: 10.1158/2159-8290.CD-21-1141. Cancer Discov. 2022. PMID: 34764195 Free PMC article. Clinical Trial.
KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma.
Luke JJ, Ascierto PA, Carlino MS, Gershenwald JE, Grob JJ, Hauschild A, Kirkwood JM, Long GV, Mohr P, Robert C, Ross M, Scolyer RA, Yoon CH, Poklepovic A, Rutkowski P, Anderson JR, Ahsan S, Ibrahim N, M Eggermont AM. Luke JJ, et al. Among authors: ahsan s. Future Oncol. 2020 Jan;16(3):4429-4438. doi: 10.2217/fon-2019-0666. Epub 2019 Dec 24. Future Oncol. 2020. PMID: 31870188 Free article.
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.
Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph R, Weber JS, Dronca R, Mitchell TC, Patnaik A, Zarour HM, Joshua AM, Zhao Q, Jensen E, Ahsan S, Ibrahim N, Ribas A. Hamid O, et al. Among authors: ahsan s. Ann Oncol. 2019 Apr 1;30(4):582-588. doi: 10.1093/annonc/mdz011. Ann Oncol. 2019. PMID: 30715153 Free PMC article. Clinical Trial.
Tetanus: a review.
Ataro P, Mushatt D, Ahsan S. Ataro P, et al. Among authors: ahsan s. South Med J. 2011 Aug;104(8):613-7. doi: 10.1097/SMJ.0b013e318224006d. South Med J. 2011. PMID: 21886075 Review.
Implantable cardioverter-defibrillators: The shock "Paradox".
Ahsan S, Tousoulis D, Papageorgiou N. Ahsan S, et al. Hellenic J Cardiol. 2020 Nov-Dec;61(6):428-429. doi: 10.1016/j.hjc.2020.12.005. Epub 2020 Dec 13. Hellenic J Cardiol. 2020. PMID: 33321183 Free article. No abstract available.
The Role of the Electrophysiologist in Convergent Ablation.
Wijesuriya N, Papageorgiou N, Maclean E, Saberwal B, Ahsan S. Wijesuriya N, et al. Among authors: ahsan s. Arrhythm Electrophysiol Rev. 2020 Jun 3;9(1):8-14. doi: 10.15420/aer.2019.06. Arrhythm Electrophysiol Rev. 2020. PMID: 32637114 Free PMC article. Review.
Formulations of Amlodipine: A Review.
Sheraz MA, Ahsan SF, Khan MF, Ahmed S, Ahmad I. Sheraz MA, et al. Among authors: ahsan sf. J Pharm (Cairo). 2016;2016:8961621. doi: 10.1155/2016/8961621. Epub 2016 Oct 16. J Pharm (Cairo). 2016. PMID: 27822402 Free PMC article. Review.
Impact of obesity on atrial fibrillation ablation.
Mangiafico V, Saberwal B, Lavalle C, Raharja A, Ahmed Z, Papageorgiou N, Ahsan S. Mangiafico V, et al. Among authors: ahsan s. Arch Cardiovasc Dis. 2020 Aug-Sep;113(8-9):551-563. doi: 10.1016/j.acvd.2020.03.023. Epub 2020 Aug 1. Arch Cardiovasc Dis. 2020. PMID: 32753124 Free article. Review.
364 results